Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
New drug approvals reached an all-time high in 2023, with five gene therapies, the first CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug.
Stanford’s SPARK program has established a process that advances academic discoveries to industry partnerships or investigator-initiated clinical trials and provides training that enhances career opportunities for its graduates.
Following the publication of AlphaFold2 and RoseTTAFold in 2021, the field of protein structure prediction has moved quickly to incorporate these advances into protein engineering.